BCM
AVNS

Boone Capital Management’s Avanos Medical AVNS Stock Holding History

Boone Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,184,909
Closed -$16.6M – 17
2026
Q1 		$16.6M Buy
+1,184,909
New +$16M 5.09% 11

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Boone Capital Management's AVNS Position: Q2 2026 in Review

Boone Capital Management sold out of Avanos Medical (AVNS) in Q2 2026, closing a stake of 1,184,909 shares — an estimated $16.6M sold.

Boone Capital Management first reported a position in AVNS in Q1 2026 and held it in 1 quarter. The position peaked at $16.6M in Q1 2026. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Boone Capital Management reported no remaining Avanos Medical position as of Q2 2026 after selling out during the quarter.
  • Boone Capital Management sold 1,184,909 Avanos Medical shares in Q2 2026, an estimated $16.6M.
  • Boone Capital Management first reported a position in Avanos Medical in Q1 2026 and held it in 1 quarter.
  • Boone Capital Management's Avanos Medical position peaked at $16.6M in Q1 2026.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Boone Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.